AbbVie Inc. (NYSE:ABBV)

Short Sellers Grow More Selective on Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Eli Lilly, Amgen and More Big Pharma Earnings to Look For This Week

The health care sector has yet to see any significant earnings representation, but that will change this week. In fact, pharmaceutical and biotech investors are about to get a real earnings ...
Read Full Story »

Will a Recent Rheumatoid Arthritis Drug Approval See Rekindled Interest?

Rheumatoid arthritis (RA) is an autoimmune disease that attacks tissues within the joints, and it is accompanied by chronic swelling and pain. This systemic disease can affect the whole body, ...
Read Full Story »

The Major Pharma Stocks That Are Making Short Sellers Sick

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Which Major Pharma Stocks Short Sellers Are Keen On

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Monday’s Biggest Winners and Losers in the S&P 500

March 26 2018: The S&P 500 closed up 2.7% at 2,658.59. The DJIA closed up 2.9% at 24,203.50. Separately, the Nasdaq was up 3.3% at 7,220.54. Monday was an incredible ...
Read Full Story »

How Analysts See AbbVie After the Big Disappointment

AbbVie Inc. (NASDAQ: ABBV) shares took a big step back last week after the firm reported less than favorable results for its relapsed/refractory small cell lung cancer (SCLC) trial. Specifically, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, American Water, Carnival, Cisco, Darden, DexCom, Micron, Nike, Occidental Petroleum and More

Stocks were hammered hard on Thursday on trade war fears, with the Dow Jones industrial average falling 724 points to 23,957 and the S&P 500 falling 68 points to 2,643.69. ...
Read Full Story »

Thursday’s Biggest Winners and Losers in the S&P 500

March 22 2018: The S&P 500 closed down 2.5% at 2,643.71. The DJIA closed down 2.9% at 23,960.20. Separately, the Nasdaq was down 2.4% at 7,166.68. Thursday was an absolute ...
Read Full Story »

AbbVie Slides on Weak Midstage Results

AbbVie Inc. (NYSE: ABBV) saw its shares pull back on Thursday after it reported less than favorable midstage results for its relapsed/refractory small cell lung cancer (SCLC) trial. Specifically, the ...
Read Full Story »

Jefferies Adds Red-Hot Retail Stock to Franchise Picks List

All Wall Street firms we follow here at 24/7 Wall St. keep a list for their institutional and retail clients of high-conviction stock picks. These are generally the stocks they ...
Read Full Story »

Major Pharma Sees Big Drop in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Jefferies Has 5 Stocks to Buy That Should Raise Dividends and Earnings

In a market that has fought its way back from a brutal 10% correction, investors are once again confronted with the reality that the market is expensive. While almost everybody ...
Read Full Story »

13 Fresh Dividend Hikes and Stock Buybacks Too Big to Ignore

It is no secret that investors love when companies pay solid dividends and when they announce strong stock buyback plans. What they love even more is when companies increase their ...
Read Full Story »